AcelRx Pharmaceuticals Inc
NASDAQ:ACRX
AcelRx Pharmaceuticals Inc
Revenue
AcelRx Pharmaceuticals Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
AcelRx Pharmaceuticals Inc
NASDAQ:ACRX
|
Revenue
$620k
|
CAGR 3-Years
-51%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-16%
|
|
Johnson & Johnson
NYSE:JNJ
|
Revenue
$81.8B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Revenue
$45.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
14%
|
CAGR 10-Years
11%
|
|
Pfizer Inc
NYSE:PFE
|
Revenue
$58.5B
|
CAGR 3-Years
12%
|
CAGR 5-Years
7%
|
CAGR 10-Years
1%
|
|
Merck & Co Inc
NYSE:MRK
|
Revenue
$61.4B
|
CAGR 3-Years
14%
|
CAGR 5-Years
7%
|
CAGR 10-Years
3%
|
|
Eli Lilly and Co
NYSE:LLY
|
Revenue
$34.1B
|
CAGR 3-Years
12%
|
CAGR 5-Years
10%
|
CAGR 10-Years
4%
|
See Also
What is AcelRx Pharmaceuticals Inc's Revenue?
Revenue
620k
USD
Based on the financial report for Sep 30, 2023, AcelRx Pharmaceuticals Inc's Revenue amounts to 620k USD.
What is AcelRx Pharmaceuticals Inc's Revenue growth rate?
Revenue CAGR 10Y
-16%
The average annual Revenue growth rates for AcelRx Pharmaceuticals Inc have been -51% over the past three years , -23% over the past five years , and -16% over the past ten years .